Tag - medicine-4

 
 

MEDICINE 4

Japan Times
WORLD / Science & Health / FOCUS
Aug 6, 2022
'Synthetic embryo' breakthrough but growing human organs far off
The breakthrough was hailed as a major step forward, though some experts said the result could not fully be considered to be embryos and warned of future ethical considerations.
Japan Times
JAPAN
Jul 29, 2022
Japan to let prefectures declare new anti-COVID measures but won't curb social activities
Governors will now be able to declare that their prefectures are in need of measures to counter the BA.5 subvariant when their health care systems are severely strained.
Japan Times
JAPAN / Science & Health / EXPLAINER
Jul 28, 2022
Everything you need to know about BA.5, the dominant strain spreading across Japan
Amid a seventh wave of infections, daily case numbers have been reaching unprecedented highs, with the nation logging 969,000 cases over the seven-day span to Sunday.
Japan Times
WORLD / Science & Health
Jul 26, 2022
Research breakthrough in mystery child hepatitis
The World Health Organization has reported at least 1,010 probable cases, including 46 that required transplants and 22 deaths from the illness dating back to last October.
Japan Times
WORLD / Science & Health
Jul 26, 2022
Siga and peers rise on optimism over therapies to treat monkeypox
It has been a bumpy few months for shares of firms tied to the outbreak, as investors have piled in only to rush out on uncertainty about what medicine could be needed.
Japan Times
JAPAN / Science & Health
Jul 20, 2022
Health ministry panel delays decision on emergency approval for Shionogi’s COVID pill
The delay is a blow to one of Japan's largest drugmakers and also raises questions about the process for drugs to gain fast-track approvals in times of emergency.
Japan Times
WORLD / Science & Health
Jul 15, 2022
U.N. sounds 'red alert' on global immunization backslide
Some 25 million children missed out on one or more doses of the vaccine against diphtheria, tetanus and pertussis DTP in 2021
Japan Times
COMMENTARY / World
Jul 14, 2022
Haven’t had COVID-19 yet? Maybe you’ve just been lucky
With highly contagious new variants in circulation, anyone who hasn't yet gotten sick can probably thank randomness or genetics more than behavior.
Japan Times
JAPAN / Science & Health
Jun 23, 2022
Japanese panel postpones verdict on Shionogi’s COVID pill until July
The panel “could not reach a conclusion,” as its members were divided over several points including the efficacy of the drug, according to a health ministry official.
Japan Times
JAPAN
Jun 21, 2022
As Japan's verdict on Shionogi's COVID pill nears, questions persist over efficacy
There have been calls for Japan to acquire more weapons against COVID-19, especially domestically produced ones, but medical experts are unsure of the drug's merits.
Japan Times
COMMENTARY / World
Jun 21, 2022
U.S. monkeypox response repeats COVID-19 mistakes
Health officials, with the monkeypox outbreak, are again failing to understand that a new epidemic may not take the same course as the last one.
Japan Times
WORLD / Science & Health
Jun 20, 2022
Where did the Black Death begin? DNA detectives find a key clue.
By fishing shards of bacterial DNA from the teeth of bodies in a cemetery, researchers found the starting point for the plague that devastated Eurasia, they say.
Japan Times
JAPAN / Science & Health / FOCUS
Jun 18, 2022
How Japan achieved one of the world’s lowest COVID-19 death rates
Health experts point to continued mask wearing, extensive vaccination and an already healthy population as the core factors behind its success.
Japan Times
COMMENTARY / World
Jun 17, 2022
What biotech innovation needs
The rapid delivery of COVID-19 vaccines has boosted everyone's appreciation for biotech research, but policymakers still need to heed the lessons of past success stories.
Japan Times
COMMENTARY / World
Jun 8, 2022
The drug that could transform breast cancer treatment
The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.
Japan Times
COMMENTARY / World
Jun 5, 2022
Omicron is turning out to be a weak vaccine
Unvaccinated people who got COVID-19 last winter have little protection from reinfection, and even vaccinated people might be vulnerable after only a few months.
Japan Times
BUSINESS
May 30, 2022
China's anti-virus spending boosts medical, tech and construction sectors
China aims to have COVID-19 testing facilities within 15-minutes' walk of everyone in its big cities and continues to impose mass testing at the slightest sign of an outbreak.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?